Skip to content

PLATFORM-COVID study; Platform randomised trial of treatments for COVID-19 in general practice

Status
Withdrawn
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2022-500678-33-00
Acronym
NL79504.068.21
Enrollment
1200
Registered
2022-07-28
Start date
Unknown
Completion date
Unknown
Last updated
2022-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with COVID-19 in the community, referred by their general practitioner, who are at higher risk of a complicated illness course.

Brief summary

The primary endpoint is time to recovery from suspected COVID-19 infection within 28 days from randomisation, defined as the first instance that a participant reports feeling recovered. This will be measured by means of a daily diary, where the participant records the answer to the question 'Do you feel fully recovered today? (i.e. symptoms associated with illness are no longer a problem)' with either yes or no.

Detailed description

Secondary outcomes include: hospital admission; hospital assessment without admission; oxygen administration; intensive care unit admission; duration of severe symptoms; sustained recovery; contacts with the health services; consumption of antibiotics; WHO Well-being Index; daily rating of how well participants feels; Safety; Death

Interventions

DRUGFILMOMHULDE TABLETTEN

Sponsors

Maastricht University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
The primary endpoint is time to recovery from suspected COVID-19 infection within 28 days from randomisation, defined as the first instance that a participant reports feeling recovered. This will be measured by means of a daily diary, where the participant records the answer to the question 'Do you feel fully recovered today? (i.e. symptoms associated with illness are no longer a problem)' with either yes or no.

Secondary

MeasureTime frame
Secondary outcomes include: hospital admission; hospital assessment without admission; oxygen administration; intensive care unit admission; duration of severe symptoms; sustained recovery; contacts with the health services; consumption of antibiotics; WHO Well-being Index; daily rating of how well participants feels; Safety; Death

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026